Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2015

Jan 12, 2015

34975_dirs_2015-01-12_93c741a5-7c48-46cf-9642-e09b38104ec2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-12-31

Reporting Person: Duchemin Jeffrey (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-31 Common Stock J 2278 $4.00 Acquired 5286 Direct

Footnotes

F1: Represents shares acquired under the Issuer's Employee Stock Purchase Plan.

F2: Represents the purchase price for each share purchased under the Employee Stock Purchase Plan and equals 85% of the fair market value of the common stock on July 1, 2014, being the offering date under the plan.